BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 5105113)

  • 1. Prevention of ventricular fibrillation during hypothermia with bretylium tosylate.
    Buckley JJ; Bosch OK; Bacaner MB
    Anesth Analg; 1971; 50(4):587-93. PubMed ID: 5105113
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of bretylium tosylate on ventricular fibrillation threshold.
    Bacaner M; Schreinemachers D; Visscher MB
    Arch Intern Med; 1969 Jul; 124(1):95-100. PubMed ID: 5791492
    [No Abstract]   [Full Text] [Related]  

  • 3. Bretylium tosylate.
    Cooper JA; Frieden J
    Am Heart J; 1971 Nov; 82(5):703-6. PubMed ID: 4940224
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical ventricular defibrillation of the human heart with bretylium tosylate.
    Sanna G; Arcidiacono R
    Am J Cardiol; 1973 Dec; 32(7):982-7. PubMed ID: 4757239
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of bretylium tosylate on the prevention and treatment of postoperative arrhythmias.
    Castaneda AR; Bacaner MB
    Am J Cardiol; 1970 Apr; 25(4):461-6. PubMed ID: 5438242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of bretylium tosylate, on the threshold of experimental auricular fibrillation].
    Gaspary FV; Guimpel A; Lodi MA; Calcaterra AC
    Medicina (B Aires); 1974; 34(5):485-90. PubMed ID: 4437386
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
    Dłuzniewski M
    Pol Tyg Lek; 1988 Oct; 43(44):1415-8. PubMed ID: 3075282
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of bretylium tosylate as prophylaxis and treatment in hypothermic ventricular fibrillation in the canine model.
    Murphy K; Nowak RM; Tomlanovich MC
    Ann Emerg Med; 1986 Oct; 15(10):1160-6. PubMed ID: 3752646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of ventricular fibrillation during induced hypothermia by N,N-diisopropyl-N'-isoamyl-N'-diethylaminoethylurea (P-286).
    Bennett CR; Smookler HH; Buckley JP
    J Pharmacol Exp Ther; 1968 Jan; 159(1):115-22. PubMed ID: 5643940
    [No Abstract]   [Full Text] [Related]  

  • 13. Bretylium tosylate and hypothermic ventricular fibrillation.
    Dronen S; Nowak RM; Tomlanovich MC
    Ann Emerg Med; 1980 Jun; 9(6):335. PubMed ID: 7386965
    [No Abstract]   [Full Text] [Related]  

  • 14. Bretylium in hypothermia-induced ventricular fibrillation in dogs.
    Elenbaas RM; Mattson K; Cole H; Steele M; Ryan J; Robinson W
    Ann Emerg Med; 1984 Nov; 13(11):994-9. PubMed ID: 6486552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.
    Bacaner M
    Int J Cardiol; 1983 Sep; 4(2):133-52. PubMed ID: 6354941
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bretylium tosylate in the management of refractory ventricular fibrillation.
    Dhurandhar RW; Teasdale SJ; Mahon WA
    Can Med Assoc J; 1971 Jul; 105(2):161-5 passim. PubMed ID: 5556280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.